ANTIBODIES WITHOUT Fc-FRAGMENT INCLUDING TWO FAB-FRAGMENT AND METHODS OF APPLICATION Russian patent published in 2017 - IPC C07K16/46 C12P21/08 A61K39/395 

Abstract RU 2617970 C2

FIELD: medicine, pharmacy.

SUBSTANCE: group of inventions refers to biotechnology, namely to bispecific antibodies, and application thereof. The bispecific antibodies comprise two Fab fragments, the first Fab fragment comprises at least one antigen-binding site specific for the first antigen and the second Fab fragment comprises at least one antigen-binding site specific for the second antigen, where variable regions or constant regions between heavy and light chains of the second Fab fragment are exchanged, at that, the bispecific antibody lacks the Fc domain. A method and a host cell for their preparation as well as a pharmaceutical composition and an immunoconjugate for cancer treatment containing such bispecific antibodies are also proposed. The advantage of the claimed bispecific antibodies is the reduced fragments aggregation, improved stability, and improved efficiency of binding to antigen.

EFFECT: invention allows effective cancer therapy.

13 cl, 23 dwg, 2 tbl, 9 ex

Similar patents RU2617970C2

Title Year Author Number
BISPECIFIC ANTIBODIES SPECIFIC FOR T-CELL ACTIVATING ANTIGENS AND A TUMOR ANTIGEN AND METHODS OF USE 2012
  • Brjunker Peter
  • Fauti Tanja
  • Eger Kristian
  • Kljajn Kristian
  • Umana Pablo
RU2605390C2
BIOSPECIFIC ANTIGEN-BINDING MOLECULES 2012
  • Auer Iogannes
  • Bryunker Peter
  • Fauti Tanya
  • Eger Kristian
  • Klyajn Kristian
  • Shefer Volfgang
  • Zustmann Klaudio
  • Umana Pablo
RU2650775C2
CD3-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND THEIR APPLICATIONS 2020
  • He, Yun
  • Shi, Lei
RU2808138C1
METHOD FOR SELECTION AND PRODUCTION OF SELECTIVE AND MULTISPECIFIC THERAPEUTIC MOLECULES WITH SPECIFIED PROPERTIES, INCLUDING, AT LEAST TWO, DIFFERENT TARGET GROUPS, AND THEIR APPLICATIONS 2013
  • Khajndl Diter
  • Khyulsmann Peter Mikhel
  • Kalutsa Brigitt
  • Kopetski Erkhard
  • Niderfellner Gerkhard
  • Tifentaler Georg
RU2644263C2
BISPECIFIC ANTIBODIES 2011
  • Brinkmann Ul'Rikh
  • Kroasdale Rebekka
  • Djurr Kharal'D
  • Kljajn Kristian
  • Kopetski Ehrkhard
  • Lau Vil'Ma
  • Regula Jorg Tomas
  • Shantser Jjurgen Mikhel'
  • Umana Pablo
  • Varta Katarina
RU2573588C2
ANTI-CD3-ANTIBODY AND MOLECULE CONTAINING THIS ANTIBODY 2017
  • Takahashi, Tohru
  • Yoshimura, Chigusa
  • Kozuma Shiho
  • Nakamura, Kensuke
  • Suzuki Chikako
  • Ichikawa Junya
RU2790326C2
PSMA×CD3 BISPECIFIC SINGLE-CHAIN ANTIBODY HAVING INTERSPECIES SPECIFICITY 2009
  • Kufer Peter
  • Raum Tobias
  • Kishel' Roman
  • Lutterbjuze Ral'F
  • Khoffmann Patrik
  • Rau Doris
  • Mangol'D Sjuzanna
  • Klinger Mattias
  • Shaller Ehvelina
  • Khausmann Sjuzanna
  • Flukhr Petra
  • Stajger Karola
RU2559531C2
MONOVALENT CARRIER MODULES ACROSS BLOOD-BRAIN BARRIER 2014
  • Ryuger Petra
  • Tifentaler Georg
  • Messner Ekkekhard
  • Nivener Ens
  • Khugenmatter Andrian
  • Shao Tsujin
  • Ros Francheska
  • Syuj Gan
RU2694659C2
UNIVERSAL TRANSMITTER MODULES THROUGH THE HEMATOENCEPHALITIC BARRIER 2014
  • Rueger, Petra
  • Tiefenthaler, Georg
  • Moessner, Ekkehard
  • Niewoehner, Jens
  • Hugenmatter, Adrian
  • Shao, Cuiying
  • Ros, Francesca
  • Xu, Gang
RU2799436C1
DUAL VARIABLE REGION ANTIBODY-LIKE BINDING PROTEINS HAVING CROSS-OVER BINDING REGION ORIENTATION 2012
  • Boren Nikolya
  • Bajl Kristian
  • Korvej Karsten
  • Lange Kristian
  • Li Dansi
  • Mikol Vensan
  • Shtajnmetts Anke
  • Rao Erkole
RU2695880C2

RU 2 617 970 C2

Authors

Bryunker Peter

Eger Kristian

Klyajn Kristian

Shefer Volfgang

Umana Pablo

Dates

2017-04-28Published

2012-08-21Filed